Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Belinostat Patent Expiration

Belinostat is Used for treating relapsed or refractory peripheral T-cell lymphoma (PTCL). It was first introduced by Acrotech Biopharma Inc in its drug Beleodaq on Jul 3, 2014.


Belinostat Patents

Given below is the list of patents protecting Belinostat, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Beleodaq US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors Aug 10, 2026 Acrotech Biopharma
Beleodaq US8835501 Pharmaceutical formulations of HDAC inhibitors Oct 27, 2027 Acrotech Biopharma


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳